All Stories

  1. The effect of the nonselective TNF inhibitor etanercept, and of the selective TNF inhibitor XPro1595 on lesioned supraspinatus muscle
  2. High-intensity resistance training in patients with myositis – 1-year follow-up on a randomised controlled trial
  3. Neurophysiology and muscle histopathology in ICU-acquired muscle weakness: Lessons learned from COVID-19
  4. Supraspinatus Muscle Regeneration Following Rotator Cuff Tear: A Study of the Biomarkers Pax7, MyoD, and Myogenin
  5. Stem cell treatment for regeneration of the rotator cuff: study protocol for a prospective single-center randomized controlled trial (Lipo-cuff)
  6. A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication
  7. High-intensity resistance training improves quality of life, muscle endurance and strength in patients with myositis: a randomised controlled trial
  8. Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation
  9. Quality of life in patients with myositis is associated with functional capacity, body composition, and disease activity—Baseline data from a randomized controlled trial
  10. Short term treatment of secondary lymphedema with hyaluronidase injections reduces mouse hindlimb lymphedema
  11. Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment
  12. Response to: Endoscopic Injections of Botulinum Toxin Type A in the Piglet Esophagus Is Safe and Feasible but Did Not Result in any Significant Structural Changes 3 Days after Injection
  13. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
  14. Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine
  15. Stone heart syndrome after prolonged cardioplegia induced cardiac arrest in open-heart surgery – a pilot study on pigs
  16. Reply to “Post‐COVID myopathy”
  17. Early-stage inflammation changes in supraspinatus muscle after rotator cuff tear
  18. Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology
  19. Endoscopic Injections of Botulinum Toxin Type A in the Piglet Esophagus Is Safe and Feasible but Did Not Result in any Significant Structural Changes 3 Days after Injection
  20. Lack of muscle stem cell proliferation and myocellular hypertrophy in sIBM patients following blood-flow restricted resistance training
  21. A mixed pattern of osteolytic and sclerotic lesions is characteristic in metastatic breast cancer patients as evidenced by histomorphometry
  22. Efficacy of bioreactor‐activated bone substitute with bone marrow nuclear cells on fusion rate and fusion mass microarchitecture in sheep
  23. Efficacy of marine bioactive compound fucoidan for bone regeneration and implant fixation in sheep
  24. Validation of a new rat model of urethral sphincter injury and leak point pressure measurements
  25. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting
  26. Oxaliplatin Neuropathy: Predictive Values of Skin Biopsy, QST and Berve Conduction
  27. High-intensity strength training in patients with idiopathic inflammatory myopathies: a randomised controlled trial protocol
  28. The inflammatory response of the supraspinatus muscle in rotator cuff tear conditions
  29. Fibrocytes in early and long-standing rheumatoid arthritis: a 6-month trial with repeated synovial biopsy, imaging and lung function test
  30. The Effect of Botulinum Toxin Type A Injections on Stricture Formation, Leakage Rates, Esophageal Elongation, and Anastomotic Healing Following Primary Anastomosis in a Long- and Short-Gap Esophageal Atresia Model – A Protocol for a Randomized, Control...
  31. Recessive Inheritance of a Rare Variant in the Nuclear Mitochondrial Gene for AARS2 in Late-Onset Dilated Cardiomyopathy
  32. Supraspinatus and deltoid muscle fiber composition in rotator cuff tear conditions
  33. C57BL/6J substrain differences in response to high-fat diet intervention
  34. The Cytotoxicity of Metal Nanoparticles Depends on Their Synergistic Interactions
  35. Comparison between stromal vascular fraction and adipose derived stem cells in a mouse lymphedema model
  36. Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke
  37. Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration
  38. Intramural Injection of Botulinum Toxin A in Surgical Treatment of a Long Gap Esophageal Atresia—Rat Model
  39. The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training
  40. Supraspinatus Muscle Fiber Composition in Rotator Cuff Tear Condition
  41. Statin use and peripheral nerve function—A prospective follow‐up study
  42. Idiopathic inflammatory myopathy
  43. Marker Expression of Interstitial Cells in Human Skeletal Muscle: An Immunohistochemical Study
  44. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy‐induced polyneuropathy symptoms and signs
  45. Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score
  46. FRI0640 COMPARING DISEASE ACTIVITY IN THE WRIST BY REPEAT SYNOVIAL BIOPSIES, RAMRIS MAGNETIC RESONANCE SCORE AND EULAR-OMERACT ULTRASOUND SCORE: A 6-MONTH PROSPECTIVE TRIAL IN EARLY AND LONGSTANDING RHEUMATOID ARTHRITIS
  47. Silver nanoparticle-induced expression of proteins related to oxidative stress and neurodegeneration in an in vitro human blood-brain barrier model
  48. Quantification of Chronic Lymphedema in a Revised Mouse Model
  49. Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
  50. BAG3 myopathy is not always associated with cardiomyopathy
  51. Mice Knocked Out for the Primary Brain Calcification–Associated Gene Slc20a2 Show Unimpaired Prenatal Survival but Retarded Growth and Nodules in the Brain that Grow and Calcify Over Time
  52. CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and Mucosa
  53. Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial
  54. The effect of low intensity shockwave treatment (Li-SWT) on human myoblasts and mouse skeletal muscle
  55. Adhesions, infl ammatory response and foreign body giant cells infi ltration of the topical hemostats TachoSil®, Hemopatch™ and Veriset™ – An Animal Study
  56. DOK7 congenital myasthenia may be associated with severe mitral valve insufficiency
  57. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis
  58. SAT0660 Safety, feasibility and tolerability of performing consecutive minimal invasive ultrasound-guided synovial biopsy procedures on the same wrist in a prospective rheumatoid arthritis study
  59. Treatment of Vesicovaginal Fistulas With Autologous Cell Injections—A Randomized Study in an Animal Model
  60. SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo
  61. Effects of scaffold materials on myoblast cell state
  62. Influence of Resistance Training on Neuromuscular Function and Physical Capacity in ALS Patients
  63. Low Oxygen Tension Enhances Expression of Myogenic Genes When Human Myoblasts Are Activated from G0 Arrest
  64. SAT0049 Circulating CD45+ CD34+ CD11B+ Cells Are Immature Fibrocytes and The Level Correlates with The Number of Mononuclear Cells That in Vitro Differentiate To Mature Fibrocytes: A Potential New Marker for Interstitial Lung Disease in Rheumatoid Arth...
  65. Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis
  66. Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65)
  67. A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene
  68. Intramural Injection with Botulinum Toxin Type A in Piglet Esophagus. The Influencer on Maximum Load and Elongation: A Dose Response Study
  69. Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
  70. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands
  71. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy
  72. Neuronal Nitric Oxide Synthase Is Dislocated in Type I Fibers of Myalgic Muscle but Can Recover with Physical Exercise Training
  73. Sympathetic block by metal clips may be a reversible operation
  74. Importance of blood cultures from peripheral veins in pediatric patients with cancer and a central venous line
  75. Duplication in the Microtubule-Actin Cross-linking Factor 1 gene causes a novel neuromuscular condition
  76. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies
  77. Glioma Spheroids Obtained via Ultrasonic Aspiration Are Viable and Express Stem Cell Markers
  78. Hormone replacement therapy increases the risk of cranial meningioma
  79. Prognostic value of Musashi-1 in gliomas
  80. Loss of Function of Slc20a2 Associated with Familial Idiopathic Basal Ganglia Calcification in Humans Causes Brain Calcifications in Mice
  81. Ageing is associated with diminished muscle re‐growth and myogenic precursor cell expansion early after immobility‐induced atrophy in human skeletal muscle
  82. A Novel In Vitro Model for Studying Quiescence and Activation of Primary Isolated Human Myoblasts
  83. Delta-Like 1 Homolog (Dlk1): A Marker for Rhabdomyosarcomas Implicated in Skeletal Muscle Regeneration
  84. Use of statins and risk of glioma: a nationwide case–control study in Denmark
  85. Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy
  86. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects
  87. The importance of being in the right spot
  88. Skeletal muscle glycogen content and particle size of distinct subcellular localizations in the recovery period after a high-level soccer match
  89. Effects of Chemotherapeutics on Organotypic Corticostriatal Slice Cultures Identified by A Panel of Fluorescent and Immunohistochemical Markers
  90. Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8-10, 2011
  91. Quantitative gene expression profiling of CD45+ and CD45− skeletal muscle‐derived side population cells
  92. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies
  93. Human skeletal muscle glycogen utilization in exhaustive exercise: role of subcellular localization and fibre type
  94. Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle
  95. Newly formed skeletal muscle fibers are prone to false positive immunostaining by rabbit antibodies
  96. CD133+ niches and single cells in glioblastoma have different phenotypes
  97. Subcellular localization-dependent decrements in skeletal muscle glycogen and mitochondria content following short-term disuse in young and old men
  98. Abstracts from the 9th Meeting of The European Association of NeuroOncology, September 16-19, 2010, Maastricht, The Netherlands
  99. Parameters in Three-Dimensional Osteospheroids of Telomerized Human Mesenchymal (Stromal) Stem Cells Grown on Osteoconductive Scaffolds That PredictIn VivoBone-Forming Potential
  100. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-β/activin/nodal signaling using SB-431542
  101. Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle
  102. Human skeletal muscle intramyofibrillar glycogen is decreased after 14 days of immobilisation in young and old men
  103. Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
  104. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
  105. An empirical analysis of the precision of estimating the numbers of neurons and glia in human neocortex using a fractionator-design with sub-sampling
  106. Lipid droplets interact with mitochondria using SNAP23
  107. “The preadipocyte factor” DLK1 marks adult mouse adipose tissue residing vascular cells that lack in vitro adipogenic differentiation potential
  108. Distinct effects of subcellular glycogen localization on tetanic relaxation time and endurance in mechanically skinned rat skeletal muscle fibres
  109. Characterization of DLK1+ Cells Emerging During Skeletal Muscle Remodeling in Response to Myositis, Myopathies, and Acute Injury
  110. Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles
  111. Teratoma Formation by Human Embryonic Stem Cells Is Site Dependent and Enhanced by the Presence of Matrigel
  112. A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
  113. Non-cultured adipose-derived CD45− side population cells are enriched for progenitors that give rise to myofibres in vivo
  114. Secreted Protein Acidic and Rich in Cysteine (SPARC) in Human Skeletal Muscle
  115. CD133 identifies perivascular niches in grade II–IV astrocytomas
  116. Immunohistochemical Markers for Quantitative Studies of Neurons and Glia in Human Neocortex
  117. Transgenic Overexpression of ADAM12 Suppresses Muscle Regeneration and Aggravates Dystrophy in Aged mdx Mice
  118. Depletion of vesicular zinc in dorsal horn of spinal cord causes increased neuropathic pain in mice
  119. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans
  120. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene
  121. Transgenic engineering of male-specific muscular hypertrophy
  122. Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells
  123. Ectopic Expression of DLK1 Protein in Skeletal Muscle of Padumnal Heterozygotes Causes the Callipyge Phenotype
  124. Enhanced procollagen processing in skeletal muscle after a single bout of eccentric loading in humans
  125. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise
  126. Adult human mesenchymal stem cell as a target for neoplastic transformation
  127. GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern
  128. Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin
  129. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased  7 integrin, utrophin and associated glycoproteins
  130. Development of acromegaly in patients with prolactinomas
  131. GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?
  132. ADAM12 Alleviates the Skeletal Muscle Pathology in mdx Dystrophic Mice
  133. Regenerating human muscle fibres express GLUT3 protein
  134. GLUT4 expression at the plasma membrane is related to fibre volume in human skeletal muscle fibres
  135. Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk
  136. Fetal Antigen 1 in Healthy Adults and Patients with Pituitary Disease: Relation to Physiological, Pathological, and Pharmacological GH Levels
  137. A cellular model system of differentiated human myotubes
  138. Fetal Antigen 1 in Healthy Adults and Patients with Pituitary Disease: Relation to Physiological, Pathological, and Pharmacological GH Levels
  139. Proliferation conditions for human satellite cells The fractional content of satellite cells
  140. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure
  141. The GLUT4 density in slow fibres is not increased in athletes. How does training increase the GLUT4 pool originating from slow fibres?
  142. Inhibitory zinc-enriched terminals in mouse spinal cord
  143. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes
  144. GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients
  145. Increased Expression of a Novel Early Activation Surface Membrane Receptor in Cutaneous T Cell Lymphoma Cells
  146. Retrograde tracing of zinc-enriched (ZEN) neuronal somata in rat spinal cord
  147. Depletion of Acyl-Coenzyme A-Binding Protein Affects Sphingolipid Synthesis and Causes Vesicle Accumulation and Membrane Defects inSaccharomyces cerevisiae
  148. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non‐functioning pituitary adenomas
  149. Induction of GLUT-1 protein in adult human skeletal muscle fibers
  150. Glucose transporter expression in human skeletal muscle fibers
  151. Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients
  152. Zinc-enriched (ZEN) terminals in mouse spinal cord: immunohistochemistry and autometallography
  153. Zinc-enriched boutons in rat spinal cord
  154. Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle
  155. Simple Numerical Chromosome Aberrations Characterize Pituitary Adenomas
  156. Stereological estimation of nuclear mean volume in invasive meningiomas
  157. Fetal antigen 1 and growth hormone in pituitary somatotroph cells
  158. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study
  159. Congenital intracranial meningioma
  160. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrence-free breast cancer patients
  161. PATHOLOGY OF SKELETAL MUSCLE IN FIBROMYALGIA: A HISTO-IMMUNO-CHEMICAL AND ULTRASTRUCTURAL STUDY
  162. Stereological estimation of nuclear volume in benign and atypical meningiomas
  163. Foetal antigen 2 (FA2) in the stromal reaction induced by breast carcinoma
  164. Symposium 6: Endocrinology
  165. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus
  166. IgD‐λ monoclonal gammaopathy and axonal neuropathy
  167. Peripheral nerve injury causes transient expression of MHC class I antigens in rat motor neurons and skeletal muscles
  168. IgM monoclonal gammopathy and neuropathy in two siblings.
  169. Axotomy induces MHC class I antigen expression on rat nerve cells
  170. HLA‐DR‐expressing cells and T‐lymphocytes in sural nerve biopsies
  171. Relation between bladder filling and anal sphincter reflexes
  172. Immunohistochemical demonstration of glial markers in retinoblastomas
  173. Relation between flexor spasms, uninhibited detrusor contractions and anal sphincter activity.
  174. Catecholamine innervation of the caudal spinal cord in the rat
  175. Somatostatin in the caudal spinal cord: An immunohistochemical study of the spinal centers involved in the innervation of pelvic organs
  176. The role of spinal pathways in dopamine mediated alteration in the tail-flick reflex in rats
  177. Neural connections between antrum and duodenum
  178. Localization of cholecystokininlike immunoreactivity in the rat spinal cord, with particular reference to the autonomic innervation of the pelvic organs
  179. Fiber types in the striated urethral and anal sphincters
  180. Anal sphincter responses after perianal electrical stimulation.
  181. Idiopathic Detrusor Sphincter Dyssynergia in Neurologically Normal Patients with Voiding Abnormalities
  182. Onuf's nucleus X: A morphological study of a human spinal nucleus
  183. Organization of the motoneurons innervating the pelvic muscles of the male rat
  184. Sulfide silver stainability of a type of bouton in spinal cord motoneuron neuropil: An electron microscopic study with Timm's method for demonstration of heavy metals
  185. ANT‐EGG CATARACT
  186. ANT‐EGG CATARACT
  187. Paramembranous densities of ?C? terminalmotoneuron synapses in the spinal cord of the rat
  188. Histochemical demonstration of mercury induced changes in rat neurons
  189. Heavy metals in the spinal cord of normal rats and of animals treated with chelating agents: A quantitative (Zinc, copper, and lead) and histochemical study
  190. POLYSACCHARIDE COATING OF HUMAN CORNEAL ENDOTHELIUM
  191. Sulfide silver architectonics of the rat, cat, and guinea pig spinal cord